02197.HK
Clover Biopharmaceuticals, Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 1.29
−0.39%Margins
Gross margin
-9099.1%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-105.3%
Return on equity
348.8%
Return on assets
34.4%
Return on invested capital
0.00x
Asset turnover
-HKD 306.3M
Cash from operations
HKD 0.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026